Difference between revisions of "Team:ColumbiaNYC"

Line 60: Line 60:
 
                 <span class="text-muted">Synthetic Biology Approach</span>
 
                 <span class="text-muted">Synthetic Biology Approach</span>
 
             </h3>
 
             </h3>
             <p class="lead">A cornerstone in synthetic biology is the connection of distinct biological functions to create useful system
+
             <p class="lead"></p>
                level behavior. We can take advantage of how bacteria naturally localize in tumors and mass produce products, invade cells,
+
                and release the products directly into the cells. This allows easily-degraded
+
                compounds to be effectively delivered and prevents these compounds from affecting healthy
+
                cells. The combination of these mechanisms creates a powerful, cancer-specific circuit for gene therapy.</p>
+
 
         </div>
 
         </div>
 
        <hr class="featurette-divider">
 
 
        <!-- Second Featurette -->
 
        <div class="featurette" id="services">
 
            <img class="featurette-image img-circle img-responsive pull-left" src="http://placehold.it/500x500">
 
            <h3 class="featurette-heading">Expanding the Possibilities of
 
                <span class="text-muted">Gene Therapy</span>
 
            </h3>
 
            <p >Anticipating the applications of synthetic biology to healthcare, we devised a therapeutic
 
                approach to modulate mammalian gene expression at the post-transcriptional level. Recombinant E. coli with
 
                the capacity to invade mammalian cells will deliver an shRNA payload against an aberrantly expressed gene,
 
                for example an oncogene in cancer or proinflammatory cytokine in inflammation, to the host cytoplasm. This
 
                shRNA payload will then inhibit protein function, which can combat mutations that confer resistance to traditional
 
                therapies, as with the tyrosine kinase inhibitors gefitinib and imatinib. </p>
 
        </div>
 
 
        <hr class="featurette-divider">
 
 
        <!-- Third Featurette -->
 
        <div class="featurette" id="contact">
 
            <img class="featurette-image img-circle img-responsive pull-right" src="http://placehold.it/500x500">
 
            <h3 class="featurette-heading">The Future
 
                <span class="text-muted">Outlook</span>
 
            </h3>
 
            <p class="lead">Our mechanism to modulate mammalian gene expression can have a variety of applications, extending throughout
 
                as well beyond healthcare. The engineered bacteria would have a significant application to human health particularly
 
                in conditions characterized by aberrant gene expression, such as with oncogenes in cancer, cytokines in inflammation,
 
                and many others. For cancer applications, the engineered bacteria can be taken as an oral probiotic, which
 
                will then selectively localize in tumor cells to prove gene therapy.</p>
 
        </div>
 
 
        <hr class="featurette-divider">
 
  
 
     </div>
 
     </div>

Revision as of 01:34, 22 October 2017

SilenshR

a Bacteria-Mediated Oncogene Silencing as Living Cancer Therapeutic

The Advantages to a Synthetic Biology Approach